DERMA-CODE™ Proof of Integrity

DERMA-CODE™ Proof of Integrity

At DERMA-CODE™, we do not rely on marketing claims.
We publish verified testing data to demonstrate formulation stability, safety, and consistency.

Each product undergoes independent stability testing, microbiological analysis, and dermatologist-supervised evaluation prior to release.

All testing was conducted in an FDA-registered, GMP-certified biotechnology facility.
Personally identifiable laboratory information has been redacted for confidentiality. All testing data and results remain unchanged.

Our Approach to Transparency

The documents below are published to provide clear, verifiable evidence of product performance under regulated cosmetic testing standards.

All claims made by DERMA-CODE™ are directly supported by the testing outcomes referenced on this page.

Accelerated Stability Testing

Both the NAD⁺ • PDRN • 6 Peptide Facial Serum and NAD⁺ • PDRN • 6 Peptide Facial Moisturizer completed a twelve-week accelerated stability study.

Observed outcomes:

  • No phase separation, color change, or visible degradation
  • pH remained consistent under light- and heat-stress conditions
  • No microbial growth detected at any test interval

These results demonstrate formulation stability under accelerated aging conditions.

Documents:

Certificate of Analysis (COA)

Each production batch was independently evaluated for physical, chemical, and microbiological parameters.

Observed results:

  • Total microbial count below 10 CFU/g (yeast and mold)
  • pH maintained within a skin-compatible range (5.0–5.7)
  • No added fragrance or colorants detected
  • Passed both elevated temperature (+40 °C) and cold (–5 °C) stress testing

Documents:

Dermatologist-Supervised Tolerance Evaluation

A 28-day dermatological tolerance evaluation was conducted under the supervision of a licensed dermatologist.

Study parameters:

  • 30 participants
  • Normal, dry, combination, oily, and sensitive skin types

Recorded observations:

  • No adverse skin reactions observed (redness, itching, burning, dryness)
  • Participants reported skin felt comfortable and hydrated during use
  • Products deemed suitable for general cosmetic use

Checkbox selections and handwritten markings within the evaluation forms reflect the original recorded outcomes.

Patch testing is recommended for individuals with highly reactive or allergy-prone skin.

Document:

Our Commitment

Transparency is foundational to DERMA-CODE™.

We publish verified data to support accountability, informed decision-making, and long-term product trust.
Each document on this page reflects testing performed to evaluate stability, purity, and cosmetic tolerance.

Frequently Asked Questions

Are these documents part of MoCRA compliance?
Yes. These reports form part of DERMA-CODE™'s internal regulatory testing library maintained in accordance with FDA and MoCRA requirements.

Why are certain sections redacted in the PDFs?
Only proprietary manufacturing identifiers and personal signatures were removed to protect confidential information. All testing data remains authentic and unaltered.